Affiliation:
1. Department of Food Science and Nutrition, Nara Women’s University, Kita-Uoya Nishimachi, Nara 630-8506, Japan
Abstract
Caveolin is a structural protein within caveolae that may be involved in transmembrane molecular transport and/or various intercellular interactions within cells. Specific mutations of caveolin-3 in muscle fibers are well known to cause limb–girdle muscular dystrophy. Altered expression of caveolin-3 has also been detected in Duchenne muscular dystrophy, which may be a part of the pathological process leading to muscle weakness. Interestingly, it has been shown that the renovation of nitric oxide synthase (NOS) in sarcolemma with muscular dystrophy could improve muscle health, suggesting that NOS may be involved in the pathology of muscular dystrophy. Here, we summarize the notable function of caveolin and/or NOS in skeletal muscle fibers and discuss their involvement in the pathology as well as possible tactics for the innovative treatment of muscular dystrophies.
Reference110 articles.
1. New therapies for Duchenne muscular dystrophy: Challenges, prospects and clinical trials;Cossu;Trends Mol. Med.,2007
2. The importance of genetic diagnosis for Duchenne muscular dystrophy;Ginjaar;J. Med. Genet.,2016
3. Joseph, J., Cho, D.S., and Doles, J.D. (2018). Metabolomic analyses reveal extensive progenitor cell deficiencies in a mouse model of duchenne muscular dystrophy. Metabolites, 8.
4. Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy;Starosta;Cell Mol. Life Sci.,2021
5. Cell based therapy for Duchenne muscular dystrophy;Farini;J. Cell Physiol.,2009